Profitability
Weight: 20%
F
0
- 5yr Avg ROIC -76.0%
- Operating Margin Trend -25.55 pp/yr
AVDL
Avadel Pharmaceuticals plc
AlphaQuality composite grade, weighted for stable earnings power businesses.
⚠ 4 of the last 5 fiscal years showed negative net income — AlphaQuality will not grade above F for persistent unprofitability in a stable earnings power business.
Grade overrides the 18.9 pillar composite — hard gates always win.
Capital Efficiency
Weight: 15%
F
0
- 5yr Avg ROE -112.9%
- 5yr Share-Count CAGR 14.7%
Growth Quality
Weight: 15%
C
56
- 5yr Revenue CAGR 65.9%
- 5yr EPS CAGR 0.0%
- Revenue-Growth Years (5) 1/5
Cash Generation
Weight: 15%
F
0
- 5yr FCF Margin -235.3%
- 5yr FCF/NI Conversion -6.95x
Balance Sheet
Weight: 20%
F
25
- Net Debt / EBITDA 10.00x
- Interest Coverage (EBIT/Int) -3.53x
- Altman Z-Score 9.06
Stability
Weight: 15%
D
36
- EPS Volatility (σ/μ) 0.83
- Piotroski F-Score 4
- Negative-Revenue Years (5) 1/5
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.0 of 2 gurus held; 3 full exits.
- Holders
- 0 -2
- Avg Δ position
- —
- New buys
- 0
- Full exits
- 3
- Cooperman sold -100%
- Greenblatt sold -100%
- Wood sold -100%